The Latest Breaking News on Pharma

WASHINGTON — Experts worry two recent rulings challenging the Food and Drug Administration’s regulation of a drug used in medication abortions threaten to complicate the agency’s oversight and the pipeline for future research and drug approvals.

The abortion pill decision proves, yet again, that there's nothing "pro-life" about Republicans

WASHINGTON — The Justice Department and several Democrat-led states took steps Monday to preserve access to a commonly used medication abortion drug after dueling federal court rulings about its availability.

The biotech sector is witnessing the headwinds from the banking crisis, layoffs, and the Inflation Reduction Act. So, fundamentally weak biotech stocks Ginkgo Bioworks Holdings (DNA) and Novavax (NVAX) might be best avoided. Read on.

The speed of which the Covid jab was developed has "unspooled" medical advancements

The fifth circuit court of appeals is considering the future of mifepristone after the supreme court blocked new restrictions

Biden has one week to appeal

The ruling from U.S. District Judge Matthew Kacsmaryk in Amarillo could potentially upend access to medication abortion nationwide.

After more than five years, three trials and countless hours of legal argument, details can finally be revealed of the brazen attempt to import 1.2 tonnes of meth into Western Australia.

The pharmaceutical industry is positioned for considerable growth in the upcoming years, thanks to increased demand, investments in research and development, and the expansion of e-pharmacy channels. Therefore, A-rated pharmaceutical stocks Astellas Pharma (ALPMY), Ono Pharmaceutical (OPHLY), and Santen Pharmaceutical (SNPHY), trading under $15, could be worth owning in April.…

The drug had been fast-tracked for approval under the agency's accelerated approval program, and has been available for more than a decade, despite the drugmaker's failure to prove that it works.